Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis sells parts of Sandoz for $1bn
Pharmaforum
Thu, 09/6/18 - 09:40 am
Tags:
Novartis, Sandoz, M&A, dermatology, Aurobindo
Novartis CAR-T therapy snags UK coverage, cutting list price 23% from US
Biopharma Dive
Wed, 09/5/18 - 10:01 pm
Tags:
Novartis, Kymriah, CAR-T, UK
Novartis to streamline production in response to lower U.S. prices: NZZ am Sonntag
Yahoo/Reuters
Sat, 09/1/18 - 03:40 pm
Tags:
Novartis, drug pricing
Novartis says glaucoma stent setback will not derail Alcon spin-off
Yahoo/Reuters
Wed, 08/29/18 - 10:34 am
Tags:
Novartis, glaucoma, Alcon, eye health, devices, CyPass Micro-Stent
Novartis announces new €78m plant and 450 new jobs to manufacture Kymriah in EU
GoinPharma
Tue, 08/28/18 - 07:58 pm
Tags:
Novartis, Europe, Kymriah, ALL, acute lymphoblastic leukemia
Novartis wins a key OK for Kymriah, but continuing manufacturing woes hobble rollout — rival Gilead CAR-T breaks into Europe
Endpoints
Mon, 08/27/18 - 10:10 am
Tags:
Novartis, CAR-T, Kymriah, drug manufacturing
LifeMax Acquires Rights to Orphan Drug for Netherton Syndrome from Novartis
CP Wire
Mon, 08/27/18 - 09:54 am
Tags:
LifeMax Laboratories, Novartis, BPR277, Netherton Syndrome
Mon, 08/27/18 - 09:12 am
Tags:
LifeMax Laboratories, Novartis, BPR277, Netherton Syndrome
Good Phase III results for Novartis’ cancer drug (breast cancer)
GoinPharma
Sun, 08/26/18 - 12:05 pm
Tags:
Novartis, clinical trials, breast cancer, BYL719, alpelisib
Novartis brings in new CEO to clean up scandal-hit Korean branch
Fierce Pharma
Fri, 08/24/18 - 11:06 am
Tags:
Novartis, Korea, kickbacks
Novartis’ PI3K drug hits goal in phase 3 breast cancer trial, laying groundwork for talks with regulators
Fierce Biotech
Thu, 08/23/18 - 10:19 am
Tags:
Novartis, PI3k inhibitor, BYL719, clinical trials, breast cancer
Gleevec antitrust suits against Novartis, after failing initially, fall short again in appeals
Fierce Pharma
Wed, 08/22/18 - 11:44 am
Tags:
Novartis, Gleevec, patents
Aimovig launch bolsters hopes for blockbuster sales
Biopharma Dive
Tue, 08/21/18 - 10:06 am
Tags:
Aimovig, Amgen, Novartis, migraines
Just a few days after a stumble, FDA OKs 12-week dose for Eylea as Regeneron braces for Novartis attack
Endpoints
Fri, 08/17/18 - 09:28 am
Tags:
FDA, Eylea, Regeneron, Novartis, wet age-related macular degeneration
CEO interrupted: Novartis chief Narasimhan looks to new ethics czar to clean up after the lingering Cohen mess
Endpoints
Tue, 08/14/18 - 11:25 am
Tags:
Novartis, Pharma CEOs, Joe Jimenez, Vasant Narasimham
Roche's Xolair, challenged in asthma, wins 'breakthrough' in food allergies
Fierce Pharma
Mon, 08/13/18 - 05:53 pm
Tags:
Novartis, Roche, Xolair, FDA, food allergies
Racing Novartis on Eylea rival, the FDA trips up Regeneron at the finish line
Endpoints
Mon, 08/13/18 - 11:39 am
Tags:
Regeneron, Eylea, Novartis, RTH258, wet age-related macular degeneration, FDA
Why Novartis Stock Gained 11% in July
Motley Fool
Mon, 08/6/18 - 09:55 am
Tags:
Novartis
Novartis licenses out unwanted GlaxoSmithKline cancer drugs to Chinese biotech
Fierce Biotech
Wed, 08/1/18 - 11:32 pm
Tags:
Novartis, China, Laekna, cancer, afuresertib, uprosertib
pH-Dependent Drug-Drug Interactions: Novartis, Merck, Gilead and More Weigh in
RAPS.org
Thu, 07/26/18 - 07:28 pm
Tags:
Novartis, Merck, GSK, Gilead Sciences, Bayer, AstraZeneca, AbbVie, Takeda, FDA, DDIs, drug-drug interactions, proton pump inhibitors

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.